Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 568

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis

Open access
Tsujikawa, Takahiro, Kumar, Sushil, Borkar, Rohan N., Azimi, Vahid, Thibault, Guillaume, Chang, Young Hwan, Balter, Ariel, Kawashima, Rie, Choe, Gina, Sauer, David, El Rassi, Edward, Clayburgh, Daniel R., Kulesz-Martin, Molly F., Lutz, Eric R., Zheng, Lei, Jaffee, Elizabeth M., Leyshock, Patrick, Margolin, Adam A., Mori, Motomi, Gray, Joe W., Flint, Paul W., Coussens, Lisa M.·2017·Cell Reports

Abstract

Here, we describe a multiplexed immunohistochemical platform with computational image processing workflows, including image cytometry, enabling simultaneous evaluation of 12 biomarkers in one formalin-fixed paraffin-embedded tissue section. To validate this platform, we used tissue microarrays containing 38 archival head and neck squamous cell carcinomas and revealed differential immune profiles based on lymphoid and myeloid cell densities, correlating with human papilloma virus status and prognosis. Based on these results, we investigated 24 pancreatic ductal adenocarcinomas from patients who received neoadjuvant GVAX vaccination and revealed that response to therapy correlated with degree of mono-myelocytic cell density and percentages of CD8 + T cells expressing T cell exhaustion markers. These data highlight the utility of in situ immune monitoring for patient stratification and provide digital image processing pipelines to the community for examining immune complexity in precious tissue sections, where phenotype and tissue architecture are preserved to improve biomarker discovery and assessment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2017.03.037

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. Affara, 2014, B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas, Cancer Cell, 25, 809, 10.1016/j.ccr.2014.04.026 · DOI · Paper page
  2. Carpenter, 2006, CellProfiler: image analysis software for identifying and quantifying cell phenotypes, Genome Biol., 7, R100, 10.1186/gb-2006-7-10-r100 · DOI · Paper page
  3. DeNardo, 2011, Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy, Cancer Discov., 1, 54, 10.1158/2159-8274.CD-10-0028 · DOI · Paper page
  4. Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139 · DOI · Paper page
  5. Gentles, 2015, The prognostic landscape of genes and infiltrating immune cells across human cancers, Nat. Med., 21, 938, 10.1038/nm.3909 · DOI · Paper page
  6. Glass, 2009, SIMPLE: a sequential immunoperoxidase labeling and erasing method, J. Histochem. Cytochem., 57, 899, 10.1369/jhc.2009.953612 · DOI
  7. Gunderson, 2016, Bruton’s tyrosine kinase-dependent immune cell cross-talk drives pancreas cancer, Cancer Discov., 6, 270, 10.1158/2159-8290.CD-15-0827 · DOI · Paper page
  8. Keck, 2014, Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes, Clin. Cancer Res., 21, 870, 10.1158/1078-0432.CCR-14-2481 · DOI · Paper page
  9. Lan, 1995, A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens, J. Histochem. Cytochem., 43, 97, 10.1177/43.1.7822770 · DOI · Paper page
  10. Liu, 2017, Trim32 deficiency enhances Th2 immunity and predisposes to features of atopic dermatitis, J. Invest. Dermatol., 137, 359, 10.1016/j.jid.2016.09.020 · DOI
  11. Lutz, 2014, Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation, Cancer Immunol. Res., 2, 616, 10.1158/2326-6066.CIR-14-0027 · DOI · Paper page
  12. Lyford-Pike, 2013, Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma, Cancer Res., 73, 1733, 10.1158/0008-5472.CAN-12-2384 · DOI · Paper page
  13. Padmanabhan, 2010, A novel algorithm for optimal image thresholding of biological data, J. Neurosci. Methods, 193, 380, 10.1016/j.jneumeth.2010.08.031 · DOI
  14. Paley, 2012, Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection, Science, 338, 1220, 10.1126/science.1229620 · DOI · Paper page
  15. Parsa, 2007, Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma, Nat. Med., 13, 84, 10.1038/nm1517 · DOI · Paper page
  16. Ruffell, 2010, Lymphocytes in cancer development: polarization towards pro-tumor immunity, Cytokine Growth Factor Rev., 21, 3, 10.1016/j.cytogfr.2009.11.002 · DOI · Paper page
  17. Ruffell, 2012, Leukocyte composition of human breast cancer, Proc. Natl. Acad. Sci. USA, 109, 2796, 10.1073/pnas.1104303108 · DOI · Paper page
  18. Ruffell, 2014, Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells, Cancer Cell, 26, 623, 10.1016/j.ccell.2014.09.006 · DOI · Paper page
  19. Ruifrok, 2003, Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution, Appl. Immunohistochem. Mol. Morphol., 11, 85, 10.1097/00129039-200303000-00014 · DOI · Paper page
  20. Soares, 2015, PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors, J. Immunother., 38, 1, 10.1097/CJI.0000000000000062 · DOI · Paper page
  21. Thurlow, 2010, Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma, J. Clin. Oncol., 28, 2881, 10.1200/JCO.2009.24.8724 · DOI
  22. Topalian, 2012, Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity, Curr. Opin. Immunol., 24, 207, 10.1016/j.coi.2011.12.009 · DOI · Paper page
  23. Tramu, 1978, An efficient method of antibody elution for the successive or simultaneous localization of two antigens by immunocytochemistry, J. Histochem. Cytochem., 26, 322, 10.1177/26.4.207771 · DOI · Paper page
  24. Wählby, 2004, Combining intensity, edge and shape information for 2D and 3D segmentation of cell nuclei in tissue sections, J. Microsc., 215, 67, 10.1111/j.0022-2720.2004.01338.x · DOI · Paper page

Cited by

See all 568

Metadata

Authors
Tsujikawa, T., Kumar, S., Borkar, R. N., Azimi, V., Thibault, G., Chang, Y. H., Balter, A., Kawashima, R., Choe, G., Sauer, D., El Rassi, E., Clayburgh, D. R., Kulesz-Martin, M. F., Lutz, E. R., Zheng, L., Jaffee, E. M., Leyshock, P., Margolin, A. A., Mori, M., Gray, J. W., Flint, P. W., & Coussens, L. M.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2017-04
Volume
19
Issue
1
Pages
203-217
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2604591951
Cited by
568
References
10
FWCI
20.68
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Oregon Clinical and Translational Research Institute (UL1TR000128)
  • National Center for Advancing Translational Sciences (NCATS) at the NIH
  • Stand Up To Cancer-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant
  • OHSU Knight Cancer Institute (P30 CA069533-17)
  • NCI (CA192405)
  • NIH
  • DOD BCRP Era of Hope Scholar Expansion Award
  • Breast Cancer Research Foundation
  • Susan B. Komen Foundation
  • Brenden-Colson Center for Pancreatic Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.